CompletedPhase 2NCT05005728
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Studying Anorectal malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xencor, Inc.
- Principal Investigator
- Jolene ShorrXencor, Inc.
- Intervention
- vudalimab + carboplatin + cabazitaxel(combination_product)
- Enrollment
- 72 target
- Eligibility
- 18 years · MALE
- Timeline
- 2021 – 2025
Study locations (26)
- Alaska Oncology and Hematology, Anchorage, Alaska, United States
- Palo Verde Hematology Oncology, Glendale, Arizona, United States
- Mayo Clinic Hospital, Phoenix, Arizona, United States
- City of Hope, Duarte, California, United States
- VA Greater Los Angeles, Los Angeles, California, United States
- University of California, San Diego, San Diego, California, United States
- Rocky Mountain Cancer Centers, Lone Tree, Colorado, United States
- Mayo Clinic, Jacksonville, Florida, United States
- The University of Chicago Medical Center, Chicago, Illinois, United States
- University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
- University of Kansas Clinical Research Center, Fairway, Kansas, United States
- Mayo Clinic, Rochester, Minnesota, United States
- GU Research Network/Urology Cancer Center, Omaha, Nebraska, United States
- Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
- XCancer New Mexico Oncology Hematology Consultants, Ltd., Albuquerque, New Mexico, United States
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05005728 on ClinicalTrials.govOther trials for Anorectal malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07441083Efficacy and Safety of Shatavari Root Extract in Women's Sexual WellnessSF Research Institute, Inc.
- RECRUITINGPHASE1NCT07545967Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After RadiotherapyWest China Hospital
- RECRUITINGNCT07438691Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian StudyMeyer Children's Hospital IRCCS
- RECRUITINGNCT07174388A Study in Non-Small Cell Lung CancerN-Power Medicine
- RECRUITINGPHASE2NCT07311577Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical StudyJiangsu Cancer Institute & Hospital
- RECRUITINGPHASE2, PHASE3NCT07369739Golidocitinib Combined With Selinexor for CAEBVDBeijing Friendship Hospital
- RECRUITINGNANCT07366476Effectiveness of Electrical Stimulation and Biofeedback on Fecal Incontinence in Children With Repaired Anorectal MalformationSinai University
- RECRUITINGNANCT07263451Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory StudyTian'an Jiang